Analyze Diet
Animals : an open access journal from MDPI2021; 11(7); 2047; doi: 10.3390/ani11072047

Nonlinear Mixed-Effect Pharmacokinetic Modeling and Distribution of Doxycycline in Healthy Female Donkeys after Multiple Intragastric Dosing-Preliminary Investigation.

Abstract: Doxycycline (DXC) is a broad-spectrum antibacterial antimicrobial administered to horses for the treatment of bacterial infections which may also affect donkeys. Donkeys have a different metabolism than horses, leading to differences in the pharmacokinetics of drugs compared to horses. This study aimed to describe the population pharmacokinetics of DXC in donkeys. Five doses of DXC hyclate (10 mg/kg) were administered via a nasogastric tube, q12 h, to eight non-fasted, healthy, adult jennies. Serum, urine, synovial fluid and endometrium were collected for 72 h following the first administration. Doxycycline concentration was measured by competitive enzyme immunoassay. Serum concentrations versus time data were fitted simultaneously using the stochastic approximation expectation-maximization algorithm for nonlinear mixed effects. A one-compartment model with linear elimination and first-order absorption after intragastric administration, best described the available pharmacokinetic data. Final parameter estimates indicate that DXC has a high volume of distribution (108 L/kg) as well as high absorption (10.3 h) in donkeys. However, results suggest that oral DXC at 10 mg/kg q12 h in donkeys would not result in a therapeutic concentration in serum, urine, synovial fluid or endometrium by comparison to the minimum inhibitory concentration of common equine pathogens. Further studies are recommended to identify appropriate dosage and dosing intervals of oral DXC in donkeys.
Publication Date: 2021-07-09 PubMed ID: 34359175PubMed Central: PMC8300337DOI: 10.3390/ani11072047Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates how the antibiotic doxycycline is processed by female donkeys, revealing that the standard dosage for this medicine may not be effective in donkeys despite its widespread use in horses.

Research context and objectives

  • The study sought to understand the pharmacokinetics—or how a drug moves through the body—of doxycycline (DXC) in female donkeys. DXC is an antimicrobial drug used to treat bacterial infections in horses, and it’s also used in donkeys, which have different metabolic systems.
  • The researchers’ objective was to determine if DXC’s current standard dosage is effective in treating bacterial infections within donkeys’ unique metabolic context.

Method

  • The team administered five doses of DXC via a nasogastric tube to eight healthy, adult female donkeys. The doses were provided every 12 hours.
  • Samples of the donkeys’ serum, urine, synovial fluid, and endometrium were collected by the researchers over 72 hours following the first dose of DXC. This allowed the team to track the medicine’s progress through the donkeys’ bodies.
  • DXC concentration was then measured within these collected samples using competitive enzyme immunoassay, a laboratory technique used to measure the concentration of substances in biological fluids.

Data Analysis

  • The outcome was analyzed using a complex statistical method called the stochastic approximation expectation-maximization algorithm, within the context of nonlinear mixed effects, to discern patterns in the pharmacokinetics data.
  • The researchers concluded that a one-compartment model with linear elimination and first-order absorption explained best how DXC spread through the donkeys’ bodies following intragastric administration.

Research Findings and Recommendations

  • The researchers found that DXC has a high volume of distribution (108 L/kg) and high absorption (10.3 h) in donkeys. Despite this, the research indicated that a dosage of 10 mg/kg administered every 12 hours wouldn’t result in a therapeutic concentration in serum, urine, synovial fluid, or endometrium when compared to the minimum inhibitory concentration of common equine pathogens.
  • The team recommended further studies to identify appropriate dosage and dosing intervals for DXC treatment in donkeys to ensure effective treatment of bacterial infections.

Cite This Article

APA
Chapuis RJJ, Smith JS, French HM, Toka FN, Peterson EW, Little EL. (2021). Nonlinear Mixed-Effect Pharmacokinetic Modeling and Distribution of Doxycycline in Healthy Female Donkeys after Multiple Intragastric Dosing-Preliminary Investigation. Animals (Basel), 11(7), 2047. https://doi.org/10.3390/ani11072047

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 11
Issue: 7
PII: 2047

Researcher Affiliations

Chapuis, Ronan J J
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, Saint Kitts and Nevis.
Smith, Joe S
  • Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA.
French, Hilari M
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, Saint Kitts and Nevis.
Toka, Felix Ngosa
  • Department of Biomedical Sciences, Ross University School of Veterinary Medicine, Basseterre, Saint Kitts and Nevis.
Peterson, Erik W
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, Saint Kitts and Nevis.
Little, Erika L
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, Basseterre, Saint Kitts and Nevis.

Grant Funding

  • 42001-2016 / Ross University School of Veterinary Medicine

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 50 references
  1. Mendoza FJ, Toribio RE, Perez-Ecija A. Donkey internal medicine—part I: Metabolic, endocrine, and alimentary tract disturbances. J. Equine Vet. Sci. 2018;65:66–74.
  2. Faye B, Konuspayeva G. The sustainability challenge to the dairy sector—The growing importance of non-cattle milk production worldwide. Int. Dairy J. 2012;24:50–56.
  3. Jirillo F, Jirillo E, Magrone T. Donkey's and goat's milk consumption and benefits to human health with special reference to the inflammatory status.. Curr Pharm Des 2010;16(7):859-63.
    doi: 10.2174/138161210790883688pubmed: 20388098google scholar: lookup
  4. Mendoza FJ, Perez-Ecija A, Toribio RE. Clinical Pharmacology in Donkeys and Mules.. Vet Clin North Am Equine Pract 2019 Dec;35(3):589-606.
    doi: 10.1016/j.cveq.2019.08.011pubmed: 31587974google scholar: lookup
  5. Lavy E, Ziv G, Glickman A. Intravenous disposition kinetics, oral and intramuscular bioavailability and urinary excretion of norfloxacin nicotinate in donkeys.. J Vet Pharmacol Ther 1995 Apr;18(2):101-7.
  6. WHO. Critically Important Antimicrobials for Human Medicine. 6th ed. World Health Organization; Geneva, Switzerland: 2019.
  7. Lees P, Svendsen O, Wiuff C. Strategies to minimize the impact of antimicrobial treatment on the selection of resistant bacteria. Guide to Antimicrobial Use in Animals Blackwell Publishing Ltd.; Oxford, UK: 2009. pp. 77–101.
  8. Baker A, Plummer CE, Szabo NJ, Barrie KP, Brooks DE. Doxycycline levels in preocular tear film of horses following oral administration.. Vet Ophthalmol 2008 Nov-Dec;11(6):381-5.
  9. Bryant JE, Brown MP, Gronwall RR, Merritt KA. Study of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations.. Equine Vet J 2000 May;32(3):233-8.
    doi: 10.2746/042516400776563608pubmed: 10836479google scholar: lookup
  10. Davis JL, Salmon JH, Papich MG. Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses.. Am J Vet Res 2006 Feb;67(2):310-6.
    doi: 10.2460/ajvr.67.2.310pubmed: 16454638google scholar: lookup
  11. Gilmour MA, Clarke CR, Macallister CG, Dedeo JM, Caudell DL, Morton RJ, Pugh M. Ocular penetration of oral doxycycline in the horse.. Vet Ophthalmol 2005 Sep-Oct;8(5):331-5.
  12. Schnabel LV, Papich MG, Watts AE, Fortier LA. Orally administered doxycycline accumulates in synovial fluid compared to plasma.. Equine Vet J 2010 Apr;42(3):208-12.
    doi: 10.2746/042516409X478514pubmed: 20486976google scholar: lookup
  13. Winther L, Honoré Hansen S, Baptiste KE, Friis C. Antimicrobial disposition in pulmonary epithelial lining fluid of horses, part II. Doxycycline.. J Vet Pharmacol Ther 2011 Jun;34(3):285-9.
  14. Zozaya H, Gutierrez L, Bernad MJ, Sumano H. Pharmacokinetics of a peroral single dose of two long-acting formulations and an aqueous formulation of doxycycline hyclate in horses.. Acta Vet Scand 2013 Mar 8;55(1):21.
    doi: 10.1186/1751-0147-55-21pmc: PMC3608154pubmed: 23497696google scholar: lookup
  15. Cypher EE, Kendall AT, Panizzi L, Stewart AJ, Taylor SL, Bodaan CJ, Riley CB, Gordon SJ, Whitfield LK. Medical and surgical management of an intra-abdominal abscess of hepatic origin in a horse.. J Am Vet Med Assoc 2015 Jul 1;247(1):98-105.
    doi: 10.2460/javma.247.1.98pubmed: 26086235google scholar: lookup
  16. Saqib M, Muhammad G, Naureen A, Hussain MH, Asi MN, Mansoor MK, Toufeer M, Khan I, Neubauer H, Sprague LD. Effectiveness of an antimicrobial treatment scheme in a confined glanders outbreak.. BMC Vet Res 2012 Nov 7;8:214.
    doi: 10.1186/1746-6148-8-214pmc: PMC3526512pubmed: 23134717google scholar: lookup
  17. Divers TJ, Gardner RB, Madigan JE, Witonsky SG, Bertone JJ, Swinebroad EL, Schutzer SE, Johnson AL. Borrelia burgdorferi Infection and Lyme Disease in North American Horses: A Consensus Statement.. J Vet Intern Med 2018 Mar;32(2):617-632.
    doi: 10.1111/jvim.15042pmc: PMC5866975pubmed: 29469222google scholar: lookup
  18. Dutra F, Schuch LF, Delucchi E, Curcio BR, Coimbra H, Raffi MB, Dellagostin O, Riet-Correa F. Equine monocytic Ehrlichiosis (Potomac horse fever) in horses in Uruguay and southern Brazil.. J Vet Diagn Invest 2001 Sep;13(5):433-7.
    doi: 10.1177/104063870101300514pubmed: 11580069google scholar: lookup
  19. Giudice E, Giannetto C, Furco V, Alongi A, Torina A. Anaplasma phagocytophilum seroprevalence in equids: a survey in Sicily (Italy).. Parasitol Res 2012 Aug;111(2):951-5.
    doi: 10.1007/s00436-012-2854-5pubmed: 22362364google scholar: lookup
  20. Rickards KJ, Thiemann AK. Respiratory Disorders of the Donkey.. Vet Clin North Am Equine Pract 2019 Dec;35(3):561-573.
    doi: 10.1016/j.cveq.2019.08.009pubmed: 31587971google scholar: lookup
  21. Mendoza FJ, Toribio RE, Perez-Ecija A. Donkey internal medicine—Part II: Cardiovascular, respiratory, neurologic, urinary, ophthalmic, dermatology, and musculoskeletal disorders. J. Equine Vet. Sci. 2018;65:86–97.
  22. Ferreira CF, Babu J, Hamlekhan A, Patel S, Shokuhfar T. Efficiency of Nanotube Surface-Treated Dental Implants Loaded with Doxycycline on Growth Reduction of Porphyromonas gingivalis.. Int J Oral Maxillofac Implants 2017 Mar Apr;32(2):322-328.
    doi: 10.11607/jomi.4975pubmed: 28291850google scholar: lookup
  23. Michilena JM, Beltrán PA, Miño LM, Velástegui JN, Ortiz IY, Estrella JV. Presencia de residuos de doxiciclina en carne bovina procedente del matadero del gobierno autónomo descentralizado del cantón mejía, Ecuador. Ecuad. Es Calid. Rev. Científica Ecuat. 2020;7.
    doi: 10.36331/revista.v7i1.102google scholar: lookup
  24. Wang J, Schneider BK, Sun P, Gong X, Qiu J, Li J, Seo YJ, Mochel JP, Cao X. Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs.. J Vet Pharmacol Ther 2019 Sep;42(5):530-540.
    doi: 10.1111/jvp.12802pubmed: 31369157google scholar: lookup
  25. Wang J, Schneider BK, Xue J, Sun P, Qiu J, Mochel JP, Cao X. Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs.. Front Vet Sci 2019;6:363.
    doi: 10.3389/fvets.2019.00363pmc: PMC6811611pubmed: 31681816google scholar: lookup
  26. Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.. CPT Pharmacometrics Syst Pharmacol 2013 Apr 17;2(4):e38.
    doi: 10.1038/psp.2013.14pmc: PMC3636497pubmed: 23887688google scholar: lookup
  27. Pelligand L, Soubret A, King JN, Elliott J, Mochel JP. Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed-Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats.. CPT Pharmacometrics Syst Pharmacol 2016 Nov;5(11):625-635.
    doi: 10.1002/psp4.12141pmc: PMC5193001pubmed: 27770596google scholar: lookup
  28. Lavielle M, Ribba B. Enhanced Method for Diagnosing Pharmacometric Models: Random Sampling from Conditional Distributions.. Pharm Res 2016 Dec;33(12):2979-2988.
    doi: 10.1007/s11095-016-2020-3pubmed: 27604892google scholar: lookup
  29. Nguyen TT, Bazzoli C, Mentré F. Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.. Stat Med 2012 May 20;31(11-12):1043-58.
    doi: 10.1002/sim.4390pubmed: 21965170google scholar: lookup
  30. Bon C, Toutain PL, Concordet D, Gehring R, Martin-Jimenez T, Smith J, Pelligand L, Martinez M, Whittem T, Riviere JE, Mochel JP. Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics.. J Vet Pharmacol Ther 2018 Apr;41(2):171-183.
    doi: 10.1111/jvp.12473pubmed: 29226975google scholar: lookup
  31. Riviere JE, Papich MG. Veterinary Pharmacology and Therapeutics. 10th ed. John Wiley & Sons; Hoboken, NJ, USA: 2018.
  32. Lizarraga I, Sumano H, Brumbaugh G. Pharmacological and pharmacokinetic differences between donkeys and horses. Equine Vet. Educ. 2004;16:102–112.
  33. Shibany KA, Pratt SL, Aldurdunji M, Totemeyer S, Paine SW. Prediction of pharmacokinetic clearance and potential Drug-Drug interactions for omeprazole in the horse using in vitro systems.. Xenobiotica 2020 Oct;50(10):1220-1227.
    doi: 10.1080/00498254.2020.1764131pubmed: 32369392google scholar: lookup
  34. Chapuis RJJ, Smith JS, Uehlinger FD, Meachem M, Johnson R, Dowling PM. Pharmacokinetics and pharmacodynamics of doxycycline in a Streptococcusequi subsp. zooepidemicus infection model in horses.. J Vet Pharmacol Ther 2021 Sep;44(5):766-775.
    doi: 10.1111/jvp.12982pubmed: 34057219google scholar: lookup
  35. Riond JL, Riviere JE, Duckett WM, Atkins CE, Jernigan AD, Rikihisa Y, Spurlock SL. Cardiovascular effects and fatalities associated with intravenous administration of doxycycline to horses and ponies.. Equine Vet J 1992 Jan;24(1):41-5.
  36. Riond JL, Riviere JE. Allometric analysis of doxycycline pharmacokinetic parameters.. J Vet Pharmacol Ther 1990 Dec;13(4):404-7.
  37. Ensink JM, van Klingeren B, Houwers DJ, Klein WR, Vulto AG. In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands.. Equine Vet J 1993 Jul;25(4):309-13.
  38. Clark C, Greenwood S, Boison JO, Chirino-Trejo M, Dowling PM. Bacterial isolates from equine infections in western Canada (1998-2003).. Can Vet J 2008 Feb;49(2):153-60.
    pmc: PMC2216435pubmed: 18309745
  39. Anzai T, Walker JA, Blair MB, Chambers TM, Timoney JF. Comparison of the phenotypes of Streptococcus zooepidemicus isolated from tonsils of healthy horses and specimens obtained from foals and donkeys with pneumonia.. Am J Vet Res 2000 Feb;61(2):162-6.
    doi: 10.2460/ajvr.2000.61.162pubmed: 10685688google scholar: lookup
  40. Prats C, El Korchi G, Giralt M, Cristòfol C, Peña J, Zorrilla I, Saborit J, Pérez B. PK and PK/PD of doxycycline in drinking water after therapeutic use in pigs.. J Vet Pharmacol Ther 2005 Dec;28(6):525-30.
  41. Cunha BA, Domenico P, Cunha CB. Pharmacodynamics of doxycycline.. Clin Microbiol Infect 2000 May;6(5):270-3.
  42. Toutain PL, Pelligand L, Lees P, Bousquet-Mélou A, Ferran AA, Turnidge JD. The pharmacokinetic/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal.. J Vet Pharmacol Ther 2021 Mar;44(2):172-200.
    doi: 10.1111/jvp.12917pubmed: 33089523google scholar: lookup
  43. Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.. J Antimicrob Chemother 2005 May;55(5):601-7.
    doi: 10.1093/jac/dki079pubmed: 15772142google scholar: lookup
  44. Barza M. The effects of protein-binding on distribution of antibiotics and the problem of continuous versus intermittent infusions. Infection 1976;4:S144–S148.
    doi: 10.1007/BF01674485google scholar: lookup
  45. Toutain PL, Lees P. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.. J Vet Pharmacol Ther 2004 Dec;27(6):467-77.
  46. Smith JS, Marmulak TL, Angelos JA, Lin Z, Rowe JD, Carlson JL, Shelver WL, Lee EA, Tell LA. Pharmacokinetic Parameters and Estimated Milk Withdrawal Intervals for Domestic Goats (Capra Aegagrus Hircus) After Administration of Single and Multiple Intravenous and Subcutaneous Doses of Flunixin Meglumine.. Front Vet Sci 2020;7:213.
    doi: 10.3389/fvets.2020.00213pmc: PMC7248982pubmed: 32509803google scholar: lookup
  47. Shelver WL, Tell LA, Wagner S, Wetzlich SE, Baynes RE, Riviere JE, Smith DJ. Comparison of ELISA and LC-MS/MS for the measurement of flunixin plasma concentrations in beef cattle after intravenous and subcutaneous administration.. J Agric Food Chem 2013 Mar 20;61(11):2679-86.
    doi: 10.1021/jf304773ppubmed: 23470029google scholar: lookup
  48. Jiang XF, Zhu YH, Liu XY. Identification of ractopamine glucuronides and determination of bioactive ractopamine residues and its metabolites in food animal urine by ELISA, LC-MS/MS and GC-MS.. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2014;31(1):29-38.
    doi: 10.1080/19440049.2013.855327pubmed: 24444392google scholar: lookup
  49. Chughtai MI, Maqbool U, Iqbal M, Shah MS, Fodey T. Development of in-house ELISA for detection of chloramphenicol in bovine milk with subsequent confirmatory analysis by LC-MS/MS.. J Environ Sci Health B 2017 Dec 2;52(12):871-879.
    doi: 10.1080/03601234.2017.1361771pubmed: 28922623google scholar: lookup
  50. Smith JS, Coetzee JF, Fisher IWG, Borts DJ, Mochel JP. Pharmacokinetics of fentanyl citrate and norfentanyl in Holstein calves and effect of analytical performances on fentanyl parameter estimation.. J Vet Pharmacol Ther 2018 Aug;41(4):555-561.
    doi: 10.1111/jvp.12501pubmed: 29603262google scholar: lookup

Citations

This article has been cited 2 times.
  1. Ebner L, O O, Simon B, Lizarraga I, Smith J, Cox S. Pharmacokinetics of butorphanol following intravenous and intramuscular administration in donkeys: A preliminary study.. Front Vet Sci 2022;9:979794.
    doi: 10.3389/fvets.2022.979794pubmed: 36213418google scholar: lookup
  2. Desanti-Consoli H, Bouillon J, Chapuis RJJ. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.. Vaccines (Basel) 2022 Mar 4;10(3).
    doi: 10.3390/vaccines10030398pubmed: 35335029google scholar: lookup